FDA says abortion pill mifepristone safety review will not be completed until March 2027
The FDA filed a legal document on October 7, 2026, stating its safety review of mifepristone will not be completed until March 2027. The review is examining complication rates and reevaluating the Biden administration's 2023 decision to allow telehealth prescribing and mail delivery of the drug. Anti-abortion activists and GOP lawmakers have accused the FDA of deliberately stalling until after the 2026 midterm elections.
33
Divergence score
This event sits in the top 19% of divergence this week. 3 outlets covered it, splitting into 3 framing camps across 2 bias groups.
3 camps
2 bias groups
The spectrum · how 3 outlets placed this story
LeftCenterRight
Politico
The Federalist
Washington Times
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
Furthest apart on this story
Politico
FDA says abortion pill review has months left
balanced with context on both sides of the legal fight · neutral
The Federalist
FDA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns
agency stalling and breaking promises to pro-life movement · negative
First to report
- Politicofirst
- Washington Times+6.8 h
- The Federalist+7.1 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
The Federalist frames the delay as deliberate stalling and two years after pledging to act; Politico notes the FDA is weighing rulings that rules were too strict alongside too loose challenges; Washington Times keeps it procedural.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 3 outlets
“FDA says abortion pill review has months left”
“FDA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns”
“Food and Drug Administration expects decision on abortion pill in March”
9 tracked claims across 3 outlets
Fact ledger
All9Claimed4Corroborated5
1/3
Claimed
More than 100 peer-reviewed studies since 2000 have found mifepristone to be overwhelmingly safe and effective
Corroborated
Disputed
8 more tracked claimsSign up free to see the full ledger